Kenneth S. Hu

Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial

Nancy Y. Lee, Qiang Zhang, David G. Pfister et al. · The Lancet Oncology · 2011 · 357 citations

Medicine, Oncology, Radiation Oncology +11

High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas

Kaled M. Alektiar, Kenneth S. Hu, Lowell L. Anderson et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 190 citations

Medicine, Oncology, Surgery +9

Phase 1b, multicenter, single blinded, placebo‐controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy

Sewanti Limaye, Robert I. Haddad, Fiona Cilli et al. · Cancer · 2013 · 126 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Radiotherapy in the management of plasma cell tumors.

Kenneth S. Hu, Joachim Yahalom · PubMed · 2000 · 119 citations

Medicine, Oncology, Radiation Oncology +16

Planned Neck Dissection after Concomitant Radiochemotherapy for Advanced Head and Neck Cancer

Douglas K. Frank, Kenneth S. Hu, B. Culliney et al. · The Laryngoscope · 2005 · 93 citations

Medicine, Oncology, Surgery +9